A nurse is teaching a newly licensed nurse about didanosine therapy. Which of the following client conditions should the nurse identify as an indication for treatment with didanosine?

Choice A rationale Tuberculosis is a bacterial infection primarily affecting the lungs, caused by *Mycobacterium tuberculosis*. Didanosine is an antiretroviral medication, specifically a nucleoside reverse transcriptase inhibitor (NRTI), and as such, it does not possess antimicrobial activity against bacterial pathogens like *Mycobacterium tuberculosis*. Therefore, it is not indicated for treating tuberculosis. Choice B rationale Human immunodeficiency virus (HIV) is a retrovirus that attacks the body's immune system. Didanosine is an antiretroviral drug that inhibits the replication of HIV by interfering with the reverse transcriptase enzyme, which is crucial for the virus to convert its RNA into DNA. This mechanism of action effectively reduces the viral load and improves immune function in individuals with HIV infection. Choice C rationale Bacterial meningitis is an inflammation of the meninges, the membranes surrounding the brain and spinal cord, caused by various bacterial species. Didanosine is an antiviral agent specifically targeting retroviruses like HIV. It does not have any direct antibacterial properties or efficacy against the common bacterial pathogens responsible for meningitis, thus making it an inappropriate treatment. Choice D rationale Syphilis is a sexually transmitted infection caused by the bacterium *Treponema pallidum*. The primary treatment for syphilis is antibiotics, particularly penicillin. Didanosine, being an antiretroviral medication, does not exhibit any treponemicidal activity and is ineffective against *Treponema pallidum*. Therefore, it is not used in the treatment of syphilis.